NCT01268553View on ClinicalTrials.gov

Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

PHASE4CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

October 5, 2016

Study Completion Date

October 5, 2016

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Treprostinil

Transition to inhaled treprostinil

Trial Locations (3)

85721

University of Arizona, Tucson

90502

Harbor-UCLA Medical Center, Torrance

94143

University of CA, San Francisco, San Francisco

Sponsors

Collaborators (1)

United Therapeutics

All Listed Sponsors

collaborator

United Therapeutics

INDUSTRY

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER